Skip to main content
Retour
Watch Compare

Renalytix plc

Qualité des données : 100%
Également cotée sous RENXF OTC
RNLXY
OTC Services Health Services
1,40 €
▲ 0,02 € (1,45%)
Cap. Boursière: 305,91 M
Prix
1,40 €
Cap. Boursière
305,91 M
Fourchette du Jour
1,35 € — 1,35 €
Fourchette 52 Semaines
1,31 € — 202,50 €
Volume
2 192
Ouverture 1,35 €
Moyenne 50J / 200J
2,69 €
48,00% below
Moyenne 50J / 200J
78,13 €
98,21% below

Quick Summary

Points Clés

Negative free cash flow of -24,44 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-32,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-1191,75%
Op. Margin-1054,93%

Sécurité

Debt / Equity
N/A
Current Ratio0,24
Interest CoverageN/A

Valorisation

PE (TTM)
-10,91
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -10,9 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % -1191,8 -19,4
Rev Growth 5Y % — 4,0
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -32,74% Revenue Growth (3Y) -12,21%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,35 M Net Income (TTM) -28,03 M
ROE N/A ROA -413,33%
Gross Margin 12,71% Operating Margin -1054,93%
Net Margin -1191,75% Free Cash Flow (TTM) -24,44 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,24
Interest Coverage N/A Asset Turnover 0,35
Working Capital -9,13 M Tangible Book Value -12,19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10,91 Forward P/E N/A
P/B Ratio N/A P/S Ratio 130,07
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,99%
Market Cap 305,91 M Enterprise Value 305,00 M
Per Share
EPS (Diluted TTM) -0,24 Revenue / Share 0,01
FCF / Share -0,11 OCF / Share -0,11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 87,20%
SBC-Adj. FCF -25,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2,29 M 3,40 M 2,97 M 1,49 M —
Net Income -33,46 M -45,61 M -45,28 M -35,34 M -9,84 M
EPS (Diluted) -0,31 -0,55 -0,67 — —
Gross Profit 156 000,0 720 000,0 874 000,0 633 000,0 —
Operating Income -29,61 M -42,22 M -53,18 M -31,92 M -10,32 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 364 000,0 508 000,0 489 000,0 282 000,0 70 000,0
Interest Expense — — — — —
Income Tax 4 000,0 2 000,0 25 000,0 — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 7,97 M 30,63 M 50,07 M 78,58 M 20,83 M
Total Liabilities 15,83 M 23,66 M 19,46 M 7,12 M 4,97 M
Shareholders' Equity -7,85 M 6,97 M 30,61 M 71,46 M 15,91 M
Total Debt — — — — —
Cash & Equivalents 4,68 M 24,68 M 41,33 M 65,13 M 13,29 M
Current Assets 6,12 M 26,88 M 44,75 M 66,79 M 14,84 M
Current Liabilities 11,50 M 16,14 M 11,78 M 7,06 M 3,29 M